(NASDAQ: STIM) Neuronetics's forecast annual revenue growth rate of 68.5% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 2.85%, and it is also forecast to beat the US market's average forecast revenue growth rate of 49.09%.
Neuronetics's revenue in 2025 is $89,448,000.On average, 1 Wall Street analysts forecast STIM's revenue for 2025 to be $9,920,442,248, with the lowest STIM revenue forecast at $9,920,442,248, and the highest STIM revenue forecast at $9,920,442,248.
In 2026, STIM is forecast to generate $10,906,431,001 in revenue, with the lowest revenue forecast at $10,906,431,001 and the highest revenue forecast at $10,906,431,001.